Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

275 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Surgical treatment of pulmonary metastases from osteosarcoma in pediatric and adolescent patients.
Steliga M, Vaporciyan A. Steliga M, et al. Among authors: vaporciyan a. Cancer Treat Res. 2009;152:185-201. doi: 10.1007/978-1-4419-0284-9_9. Cancer Treat Res. 2009. PMID: 20213391 Review. No abstract available.
A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.
Ajani JA, Komaki R, Putnam JB, Walsh G, Nesbitt J, Pisters PW, Lynch PM, Vaporciyan A, Smythe R, Lahoti S, Raijman I, Swisher S, Martin FD, Roth JA. Ajani JA, et al. Among authors: vaporciyan a. Cancer. 2001 Jul 15;92(2):279-86. doi: 10.1002/1097-0142(20010715)92:2<279::aid-cncr1320>3.0.co;2-2. Cancer. 2001. PMID: 11466680 Clinical Trial.
BACKGROUND: Patients with locoregional carcinoma of the esophagus or gastroesophageal junction have a poor survival rate after surgery. ...According to EUS classification, 31 (89%) of the 35 patients who underwent surgery had a T3 carcinoma whereas according to path …
BACKGROUND: Patients with locoregional carcinoma of the esophagus or gastroesophageal junction have a poor survival rate after surger …
Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction.
Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam JB Jr, Lynch PM, Wu TT, Smythe R, Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA. Ajani JA, et al. Among authors: vaporciyan a. Cancer. 2004 Jun 1;100(11):2347-54. doi: 10.1002/cncr.20284. Cancer. 2004. PMID: 15160337
Patients who had achieved a pathCR or pathPR had a longer median survival (25.6 months) than those who achieved less than a pathPR (18.5 months; P = 0.52). ...CONCLUSIONS: CPT-11-based induction chemotherapy resulted in substantial pathCR and pathPR rates, bo …
Patients who had achieved a pathCR or pathPR had a longer median survival (25.6 months) than those who achieved less than a
Outcomes after surgical resection of cardiac sarcoma in the multimodality treatment era.
Bakaeen FG, Jaroszewski DE, Rice DC, Walsh GL, Vaporciyan AA, Swisher SS, Benjamin R, Blackmon S, Reardon MJ. Bakaeen FG, et al. Among authors: vaporciyan aa. J Thorac Cardiovasc Surg. 2009 Jun;137(6):1454-60. doi: 10.1016/j.jtcvs.2008.11.026. Epub 2009 Apr 2. J Thorac Cardiovasc Surg. 2009. PMID: 19464464
Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients.
Harting MT, Lally KP, Andrassy RJ, Vaporciyan AA, Cox CS Jr, Hayes-Jordan A, Blakely ML. Harting MT, et al. Among authors: vaporciyan aa. J Cancer Res Clin Oncol. 2010 Apr;136(4):561-70. doi: 10.1007/s00432-009-0690-5. Epub 2009 Sep 27. J Cancer Res Clin Oncol. 2010. PMID: 19784847
Our aim was to understand if age at diagnosis is a prognostic indicator for eventual outcome, as measured by disease-free survival and overall survival in patients with osteosarcoma. ...Age was not identified a statistically significant prognostic variable on multiv …
Our aim was to understand if age at diagnosis is a prognostic indicator for eventual outcome, as measured by disease-free survival an …
Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.
Blum Murphy M, Xiao L, Patel VR, Maru DM, Correa AM, G Amlashi F, Liao Z, Komaki R, Lin SH, Skinner HD, Vaporciyan A, Walsh GL, Swisher SG, Sepesi B, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Ajani JA. Blum Murphy M, et al. Among authors: vaporciyan a. Cancer. 2017 Nov 1;123(21):4106-4113. doi: 10.1002/cncr.30953. Epub 2017 Sep 8. Cancer. 2017. PMID: 28885712
This study examines the association of a pathCR with pretreatment variables, overall survival (OS), recurrence-free survival (RFS), and patterns of recurrence in a large cohort from a single institution. ...A pathCR was defined as a surgical spe …
This study examines the association of a pathCR with pretreatment variables, overall survival (OS), recurrence-free survival (RFS), a …
Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases.
Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJ. Nelson DB, et al. Among authors: vaporciyan aa. J Thorac Cardiovasc Surg. 2019 Apr;157(4):1648-1655. doi: 10.1016/j.jtcvs.2018.10.156. Epub 2018 Nov 26. J Thorac Cardiovasc Surg. 2019. PMID: 30635188
METHODS: A retrospective study of patients who underwent a wedge resection for colorectal pulmonary metastases from 2006 to 2016 was performed. ...However, the increased risk of local recurrence with larger tumors was diminished with a sufficient margin lengt …
METHODS: A retrospective study of patients who underwent a wedge resection for colorectal pulmonary metastases from 2006 to 20 …
Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients.
Wagner KW, Ye Y, Lin J, Vaporciyan AA, Roth JA, Wu X. Wagner KW, et al. Among authors: vaporciyan aa. Clin Cancer Res. 2012 Jan 15;18(2):585-92. doi: 10.1158/1078-0432.CCR-11-2087. Clin Cancer Res. 2012. PMID: 22252258 Free PMC article.
Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival.
Blackmon SH, Shah N, Roth JA, Correa AM, Vaporciyan AA, Rice DC, Hofstetter W, Walsh GL, Benjamin R, Pollock R, Swisher SG, Mehran R. Blackmon SH, et al. Among authors: vaporciyan aa. Ann Thorac Surg. 2009 Sep;88(3):877-84; discussion 884-5. doi: 10.1016/j.athoracsur.2009.04.144. Ann Thorac Surg. 2009. PMID: 19699915
RESULTS: Groups A, B1, and B2 consisted of 147 (62.8%), 26 (11.1%), and 13 (5.6%) patients, respectively. The median survival from lung metastasectomy date was 35.5, 37.8, and 13.5 months in groups A, B1, and B2, respectively. Comparison among the three groups showe …
RESULTS: Groups A, B1, and B2 consisted of 147 (62.8%), 26 (11.1%), and 13 (5.6%) patients, respectively. The median survival from lu …
Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer.
Blackmon SH, Stephens EH, Correa AM, Hofstetter W, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Blackmon SH, et al. Among authors: vaporciyan aa. Ann Thorac Surg. 2012 Dec;94(6):1802-9. doi: 10.1016/j.athoracsur.2012.07.014. Epub 2012 Oct 11. Ann Thorac Surg. 2012. PMID: 23063195
METHODS: A prospectively collected database was retrospectively reviewed to identify patients who underwent their first colorectal carcinoma pulmonary metastasectomy. ...
METHODS: A prospectively collected database was retrospectively reviewed to identify patients who underwent their first colorectal ca …
275 results
Jump to page
Feedback